ArticleBMC musculoskeletal disorders2025
Hidden blood loss and its risk factors between high tibial osteotomy and unicompartmental knee arthroplasty for knee osteoarthritis: a retrospective study.
Article in BMC musculoskeletal disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe aim of our study was to compare the hidden blood loss (HBL) between patients treated with unicompartmental knee arthroplasty (UKA) and high tibial osteotomy (HTO) and to identify predictors of HBL in this cohort.
methodsWe conducted a retrospective study including 91 patients who had knee osteoarthritis, of which 31 cases (male/female: 12/19) received HTO and 60 cases (male/female: 24/36) received UKA, from January 2021 to January 2023. Demographics, clinical information and laboratory values were collected and compared. Recording preoperative and postoperative hematocrit and estimating intraoperative blood loss by surgeon to calculate HBL according to Nadler, Gross and Sehat formula. Effect sizes were determined using Cohen's d and Glass rank biserial correlation coefficient to assess clinical difference in the data. The Spearman correlation analysis was used to investigate an association between patient's characteristics and HBL. Multiple linear regression analysis was used to confirm independent risk factors of HBL.
resultsThe HBL and TBL of the HTO group (534.49 ± 336.05 ml, 639.65 ± 337.81 ml, respectively) are significantly higher than that in the UKA group (359.42 ± 263.51 ml, 408.76 ± 283.50 ml, respectively; P = 0.008, P = 0.001). Effect size analysis indicated moderate clinical significance (Cohen's d [95% CI] = 0.604 [0.160, 1.045] for HBL, 0.762 [0.312, 1.208] for TBL). The multiple linear regression analysis suggested post-operative hemoglobin values and hemoglobin loss were independent risk factors for HBL in the UKA and HTO groups.
conclusionThis study provides new insights into the comparative blood loss between HTO and UKA procedures, highlighting that HBL and TBL are significantly higher in HTO than in UKA. The moderate clinical significance of this difference emphasize the need for careful management of post-operative anemia, particularly in patients undergoing HTO, where blood loss may be more pronounced. Its risk factors should be paid more attention during the perioperative period. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.